Search Results - "Parra, E.R."

Caryocar brasiliense camb protects against genomic and oxidative damage in urethane-induced lung carcinogenesis by Colombo, N B R, Rangel, M P, Martins, V, Hage, M, Gelain, D P, Barbeiro, D F, Grisolia, C K, Parra, E R, Capelozzi, V L

“…The antioxidant effects of Caryocar brasiliense Camb, commonly known as the pequi fruit, have not been evaluated to determine their protective effects against…”
Get full text

Immunohistochemical detection of virus through its nuclear cytopathic effect in idiopathic interstitial pneumonia other than acute exacerbation by Santos, G C Dos, Parra, E R, Stegun, F W, Cirqueira, C S, Capelozzi, V L

“…Idiopathic interstitial pneumonias include complex diseases that have a strong interaction between genetic makeup and environmental factors. However, in many…”
Get full text

Tissue hyaluronan expression, as reflected in the sputum of lung cancer patients, is an indicator of malignancy by Rangel, M P, de Sá, V K, Martins, V, Martins, J R M, Parra, E R, Mendes, A, Andrade, P C, Reis, R M, Longatto-Filho, A, Oliveira, C Z, Takagaki, T, Carraro, D M, Nader, H B, Capelozzi, V L

“…Hyaluronan (HA) shows promise for detecting cancerous change in pleural effusion and urine. However, there is uncertainty about the localization of HA in tumor…”
Get full text

Modeling pulmonary fibrosis by abnormal expression of telomerase/apoptosis/collagen V in experimental usual interstitial pneumonia by Parra, E R, Pincelli, M S, Teodoro, W R, Velosa, A P P, Martins, V, Rangel, M P, Barbas-Filho, J V, Capelozzi, V L

“…Limitations on tissue proliferation capacity determined by telomerase/apoptosis balance have been implicated in pathogenesis of idiopathic pulmonary fibrosis…”
Get full text

Morphometric evaluation of nitric oxide synthase isoforms and their cytokine regulators predict pulmonary dysfunction and survival in systemic sclerosis by Parra, E R, Aguiar Junior, A C, Silva, L O, Souza, H S P, Espinoza, J D, Capelozzi, V L

“…Because histopathological changes in the lungs of patients with systemic sclerosis (SSc) are consistent with alveolar and vessel cell damage, we presume that…”
Get full text

Vascular dysfunction by myofibroblast activation in patients with idiopathic pulmonary fibrosis and prognostic significance by Parra, E R, Falzoni, R, Capelozzi, V L

“…In this study, we demonstrated the importance of telomerase protein expression and determined the relationships among telomerase, endothelin-1 (ET-1) and…”
Get full text

Lymphatic fluctuation in the parenchymal remodeling stage of acute interstitial pneumonia, organizing pneumonia, nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis by Parra, E R, Araujo, C A L, Lombardi, J G, Ab'Saber, A M, Carvalho, C R R, Kairalla, R A, Capelozzi, V L

“…Because the superficial lymphatics in the lungs are distributed in the subpleural, interlobular and peribroncovascular interstitium, lymphatic impairment may…”
Get full text

Ultra high dilution of triiodothyronine modifies cellular apoptosis in Rana catesbeiana tadpole tail in vitro by Guedes, J R P, Carrasco, S, Ferreira, C M, Bonamin, L V, Souza, W, Goldenstein-Schainberg, C, Parra, E R, Capelozzi, V L

“…Ultra High Dilutions (UHD) are diluted beyond the Avogadro limit with dynamization (dilution with succussion). The process of anuran amphibian metamorphosis is…”
Get more information

Lymphatic fluctuation in the parenchymal remodeling stage of acute interstitial pneumonia, organizing pneumonia, nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis by Parra, E.R., Araujo, C.A.L., Lombardi, J.G., Ab’Saber, A.M., Carvalho, C.R.R., Kairalla, R.A., Capelozzi, V.L.

“…Because the superficial lymphatics in the lungs are distributed in the subpleural, interlobular and peribroncovascular interstitium, lymphatic impairment may…”
Get full text

Demographic, Etiologic and Histologic Pulmonary Analysis in Patients with HIV/AIDS and Acute Respiratory Failure - An Autopsy Study by Soeiro, A.M, Hovnanian, A.L.D, Canzian, M, Parra, E.R, Farhat, C, Capelozzi, V.L

Get full text

p53 immunostaining is correlated with reduced survival and is not correlated with gene mutations in resected pulmonary large cell carcinomas by Massoni Neto, L M, Bianchi, C P, Ab'Saber, A M, Parra, E R, Takagaki, T, Pereira, J C, Soares, F A, Leite, K, Capelozzi, V L

“…Malignancy of pulmonary large cell carcinomas (LCC) increases from classic LCC through LCC with neuroendocrine morphology (LCCNM) to large cell neuroendocrine…”
Get full text

Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer by Kudo, Y., Haymaker, C., Zhang, J., Reuben, A., Duose, D.Y., Fujimoto, J., Roy-Chowdhuri, S., Solis Soto, L.M., Dejima, H., Parra, E.R., Mino, B., Abraham, R., Ikeda, N., Vaporcyan, A., Gibbons, D., Zhang, J., Lang, F.F., Luthra, R., Lee, J.J., Moran, C., Huse, J.T., Kadara, H., Wistuba, I.I.

“…The tumor immune microenvironment (TIME) of lung cancer brain metastasis is largely unexplored. We carried out immune profiling and sequencing analysis of…”
Get full text

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up by Kadara, H, Choi, M, Zhang, J., Parra, E.R., Rodriguez-Canales, J., Gaffney, S.G., Zhao, Z., Behrens, C., Fujimoto, J., Chow, C., Yoo, Y., Kalhor, N., Moran, C., Rimm, D., Swisher, S., Gibbons, D.L., Heymach, J., Kaftan, E., Townsend, J.P., Lynch, T.J., Schlessinger, J., Lee, J., Lifton, R.P., Wistuba, I.I., Herbst, R.S.

“…Lung adenocarcinomas (LUADs) lead to the majority of deaths attributable to lung cancer. We performed whole-exome sequencing (WES) and immune profiling…”
Get full text

Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function by Choi, M., Kadara, H., Zhang, J., Parra, E.R., Rodriguez-Canales, J., Gaffney, S.G., Zhao, Z., Behrens, C., Fujimoto, J., Chow, C., Kim, K., Kalhor, N., Moran, C., Rimm, D., Swisher, S., Gibbons, D.L., Heymach, J., Kaftan, E., Townsend, J.P., Lynch, T.J., Schlessinger, J., Lee, J., Lifton, R.P., Herbst, R.S., Wistuba, I.I.

“…Lung squamous cell carcinoma (LUSC) accounts for 20–30% of non-small cell lung cancers (NSCLCs). There are limited treatment strategies for LUSC in part due to…”
Get full text

1024P Baseline biomarkers associated with clinical benefit in patients with solid tumors refractory to immune checkpoint inhibitors (ICIs) treated with live biotherapeutic MRx0518 in combination with pembrolizumab by Parra, E.R., Adriani, M., Freitas Pinto Lima, C., Li, J., Haymaker, C., Parikh, R., Bernicker, E., Davar, D., Chaudhry, A., Stevenson, A., Badham, C., Fyvie, G., Chisamore, M., Pant, S.

Get full text

7P Distinct immune gene programs associated with host tumor immunity, neoadjuvant chemotherapy and chemoimmunotherapy in resectable NSCLC by Rocha, P., Zhang, J., Laza-Briviesca, R., Cruz-Bermúdez, A., Yoshimura, K., Behrens, C., Pataer, A., Parra, E.R., Haymaker, C., Fujimoto, J., Swisher, S.G., Heymach, J.V., Gibbons, D.L., Lee, J.J., Sepesi, B., Cascone, T., Solis, L.M., Provencio, M., Kadara, H., Wistuba, I.I.

Get full text

A Validation of Immune Pathology-Based Radiomics Signature With Stage I NSCLC Treated With SABR by Yu, W., Tang, C., Hobbs, B., Li, X., Wistuba, I., Koay, E.J., Behrens, C., Cuentas, E.R. Parra, Canales, J. Rodriguez, Court, L.E., Chang, J.Y.

Get full text

LKB1 loss is a novel genomic predictor of de novo resistance to PD-1/PD-L1 axis blockade in KRAS-mutant lung adenocarcinoma by Skoulidis, F., Hellman, M.D., Awad, M., Gainor, J.F., Rizvi, H., Carter, B., Denning, W.L., Villalobos, P., Parra, E.R., Elamin, Y.Y., Zhang, J., Leonardi, G.C., Halpenny, D.F., Papadimitrakopoulou, V., Wistuba, I.I., Wolchok, J.D., Shaw, A.T., Jänne, P.A., Rudin, C.M., Heymach, J.V.

Get full text

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up by Kadara, H., Choi, M., Zhang, J., Parra, E.R., Rodriguez-Canales, J., Gaffney, S.G., Zhao, Z., Behrens, C., Fujimoto, J., Chow, C., Yoo, Y., Kalhor, N., Moran, C., Rimm, D., Swisher, S., Gibbons, D.L., Heymach, J., Kaftan, E., Townsend, J.P., Lynch, T.J., Schlessinger, J., Lee, J., Lifton, R.P., Wistuba, I.I., Herbst, R.S.

Get full text

28P Decoding biomarkers of immune activation in neuroendocrine carcinomas treated with ipilimumab and nivolumab using a multiomic approach by Haymaker, C., Kumar, G., Chae, Y.K., Gonzalez-Kozlova, E., Duault, C., Zhang, J., Othus, M., Soto, L. Solis, Manyam, G., Jiang, P., Parra, E.R., Fernandez, C. Laberiano, Reuben, A., Maecker, H., Gnjatic, S., Al-Atrash, G., Zhang, J., Lee, J.J., Patel, S.P., Kurzrock, R.

Get full text